GSK3B and colonic neoplasm: The research found that the inhibition of SIRT4 would activate GLS, thereby initiating AKT activation, suggesting that GLS might influence the proliferation, migration, and invasion of colon cancer cells through the AKT/GSK3β/CyclinD1 pathway under the regulation of SIRT4 [29].